Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk

Endocrine-Related Cancer

Volumn 18, Issue 2, 2011, Pages 265-276

  Sainz, J ^a   Rudolph, A ^a   Hein, R ^a   Hoffmeister, M ^a   Buch, S ^b   Von Schonfels W ^b   Hampe, J ^b   Schafmayer, C ^b   Volzke H ^c   Frank, B ^a   Brenner, H ^a   Forsti A ^a,d   Hemminki, K ^a,d   Chang Claude, J ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d Clinical Research Center   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOCHROME; CYTOCHROME P450 17A1; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUTATHIONE TRANSFERASE P1; HYDROXYSTEROID 17BETA DEHYDROGENASE 1; HYDROXYSTEROID DEHYDROGENASE; MULTIDRUG RESISTANCE PROTEIN 1; NUCLEAR PROTEIN; NUCLEAR RECEPTOR NR1I2; PREGNANE X RECEPTOR; PROGESTERONE RECEPTOR; SEX HORMONE BINDING GLOBULIN; STEROID HORMONE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; COLORECTAL NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; ESTRADIOL DEHYDROGENASES; ESTROGEN RECEPTOR BETA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; SEX FACTORS;

EID: 79953205910     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-10-0264     Document Type: Article

References (43)

1. Aird RE, Thomson M, Macpherson JS, Thurston DE, Jodrell DI & Guichard SM 2008 ABCB1 genetic polymorphism influences the pharmacology of the new pyrrolobenzodiazepine derivative SJG-136. Pharmacogenomics Journal 8 289-296. (doi:10.1038/sj.tpj.6500465)
2. Aka JA, Mazumdar M, Chen CQ, Poirier D & Lin SX 2010 17β-Hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production. Molecular Endocrinology 24 832-845. (doi:10.1210/me.2009-0468)
3. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E & Vergote I 2005 Endometrial cancer. Lancet 366 491-505. (doi:10.1016/S0140-6736(05)67063- 8)
4. Arai N, Strom A, Rafter JJ & Gustafsson JA 2000 Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochemical and Biophysical Research Communications 270 425-431. (doi:10.1006/bbrc.2000.2444)
5. Bethke L, Webb E, Sellick G, Rudd M, Penegar S, Withey L, Qureshi M & Houlston R 2007 Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk. BMC Cancer 7 123. (doi:10.1186/1471-2407-7-123)
6. Beral V, Bull D, Green J & Reeves G 2007 Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 369 1703-1710. (doi:10.1016/S0140-6736(07)60534-0)
7. Bjornstrom L & Sjoberg M 2005 Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Molecular Endocrinology 19 833-842. (doi:10.1210/me.2004-0486)
8. Brenner H, Chang-Claude J, Seiler CM, Sturmer T & Hoffmeister M 2006 Does a negative screening colonoscopy ever need to be repeated? Gut 55 1145-1150. (doi:10.1136/gut.2005.087130)
9. Caiazza F, Galluzzo P, Lorenzetti S & Marino M 2007 17β-Estradiol induces ERbeta up-regulation via p38/MAPK activation in colon cancer cells. Biochemical and Biophysical Research Communications 359 102-107. (doi:10.1016/j.bbrc.2007.05.059)
10. Clendenen TV, Koenig KL, Shore RE, Levitz M, Arslan AA & Zeleniuch-Jacquotte A 2009 Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention 18 275-281. (doi:10.1158/1055-9965.EPI-08-0777)
11. Cousin P, Dechaud H, Grenot C, Lejeune H, Hammond GL & Pugeat M 1999 Influence of glycosylation on the clearance of recombinant human sex hormone-binding globulin from rabbit blood. Journal of Steroid Biochemistry and Molecular Biology 70 115-121. (doi:10.1016/S0960-0760(99)00101-6)
12. Cousin P, Calemard-Michel L, Lejeune H, Raverot G, Yessaad N, Emptoz-Bonneton A, Morel Y & Pugeat M 2004 Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women. Journal of Clinical Endocrinology and Metabolism 89 917-924. (doi:10.1210/jc.2002-021553)
13. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD et al. 2004 Polymorphisms associated with circulating sex hormone levels in postmenopausal women. Journal of the National Cancer Institute 96 936-945. (doi:10.1093/jnci/djh167)
14. Ferlay J, Shin HR, Bray F, Forman D, Mathers C & Parkin DM 2010 Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127 2893-2917. (doi:10.1002/ijc.25516)
15. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O & Rice LW 2000 Selective loss of estrogen receptor beta in malignant human colon. Cancer Research 60 245-248. (Pubitemid 30070743)
16. Frank B, Hoffmeister M, Klopp N, Illig T, Chang-Claude J & Brenner H 2010 Colorectal cancer and polymorphisms in DNA repair genes WRN, RMI1 and BLM. Carcinogenesis 31 442-445. (doi:10.1093/carcin/bgp293)
17. Hendifar A, Yang D, Lenz F, Lurje G, Pohl A, Lenz C, Ning Y, Zhang W & Lenz HJ 2009 Gender disparities in metastatic colorectal cancer survival. Clinical Cancer Research 15 6391-6397. (doi:10.1158/1078-0432.CCR-09-0877)
18. Hoffmeister M, Raum E, Winter J, Chang-Claude J & Brenner H 2007 Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany. British Journal of Cancer 97 1486-1492. (doi:10.1038/sj.bjc.6604066)
19. Hoffmeister M, Raum E, Krtschil A, Chang-Claude J & Brenner H 2009 No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy. Clinical Pharmacology and Therapeutics 86 416-424. (doi:10.1038/clpt.2009.134)
20. Kahn SM, Hryb DJ, Nakhla AM, Romas NA & Rosner W 2002 Sex hormone-binding globulin is synthesized in target cells. Journal of Endocrinology 175 113-120. (doi:10.1677/joe.0.1750113)
21. Kennelly R, Kavanagh DO, Hogan AM & Winter DC 2008 Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncology 9 385-391. (doi:10.1016/S1470-2045(08)70100-1)
22. Kiss I, Orsos Z, Gombos K, Bogner B, Csejtei A, Tibold A, Varga Z, Pazsit E, Magda I, Zolyomi A et al. 2007 Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. Anticancer Research 27 2931-2937. (Pubitemid 47228023)
23. Koo JH & Leong RW 2010 Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. Journal of Gastroenterology and Hepatology 25 33-42. (doi:10.1111/j.1440-1746.2009.05992.x)
24. Lascorz J, Forsti A, Chen B, Buch S, Steinke V, Rahner N, Holinski-Feder E, Morak M, Schackert HK, Gorgens H et al. 2010 Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility. Carcinogenesis 31 1612-1619. (doi:10.1093/carcin/bgq146)
25. La Vecchia C, Gallus S & Fernandez E 2005 Hormone replacement therapy and colorectal cancer: an update. Journal of the British Menopause Society 11 166-172. (doi:10.1258/136218005775544264)
26. Li C, Briggs MR, Ahlborn TE, Kraemer FB & Liu J 2001 Requirement of Sp1 and estrogen receptor alpha interaction in 17beta-estradiol-mediated transcriptional activation of the low density lipoprotein receptor gene expression. Endocrinology 142 1546-1553. (doi:10.1210/en.142.4.1546)
27. Lin J, Zee RY, Liu KY, Zhang SM, Lee IM, Manson JE, Giovannucci E, Buring JE & Cook NR 2010 Genetic variation in sex-steroid receptors and synthesizing enzymes and colorectal cancer risk in women. Cancer Causes & Control 21 897-908. (doi:10.1007/s10552-010-9518-5)
28. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price RH Jr, Pestell RG & Kushner PJ 2002 Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. Journal of Biological Chemistry 277 24353-24360. (doi:10.1074/jbc. M201829200)
29. Mustonen MV, Poutanen MH, Kellokumpu S, de Launoit Y, Isomaa VV, Vihko RK & Vihko PT 1998 Mouse 17 beta-hydroxysteroid dehydrogenase type 2 mRNA is predominantly expressed in hepatocytes and in surface epithelial cells of the gastrointestinal and urinary tracts. Journal of Molecular Endocrinology 20 67-74. (doi:10.1677/jme.0.0200067)
30. Nakamura T, Okamura N, Yagi M, Omatsu H, Yamamori M, Kuwahara A, Nishiguchi K, Horinouchi M, Okumura K & Sakaeda T 2009 Effects of ABCB1 3435C>T genotype on serum levels of cortisol and aldosterone in women with normal menstrual cycles. Genetics and Molecular Research 8 397-403. (doi:10.4238/vol8-2gmr574)
31. Newcomb PA, Zheng Y, Chia VM, Morimoto LM, Doria-Rose VP, Templeton A, Thibodeau SN & Potter JD 2007 Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Research 67 7534-7539. (doi:10.1158/0008-5472.CAN-06-4275)
32. Reeves GK, Beral V, Green J, Gathani T & Bull D 2006 Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncology 7 910-918. (doi:10.1016/S1470-2045(06)70911-1)
33. Safe S 2001 Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitamins & Hormones 62 231-252. (doi:10.1016/S0083-6729(01)62006-5)
34. Saloniemi T, Jarvensivu P, Koskimies P, Jokela H, Lamminen T, Ghaem-Maghami S, Dina R, Damdimopoulou P, Makela S, Perheentupa A et al. 2010 Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice. American Journal of Pathology 176 1443-1451. (doi:10.2353/ajpath.2010.090325)
35. Siest G, Marteau JB, Maumus S, Berrahmoune H, Jeannesson E, Samara A, Batt AM & Visvikis-Siest S 2005 Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers. European Journal of Pharmacology 527 1-22. (doi:10.1016/j.ejphar.2005.10.011)
36. Slattery ML, Sweeney C, Murtaugh M, Ma KN, Wolff RK, Potter JD, Caan BJ & Samowitz W 2005 Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Cancer Epidemiology, Biomarkers & Prevention 14 2936-2942. (doi:10.1158/1055-9965.EPI-05-0514)
37. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I & Willingham MC 1987 Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. PNAS 84 7735-7738. (doi:10.1073/pnas.84. 21.7735)
38. Tsuchiya Y, Nakajima M & Yokoi T 2005 Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Letters 227 115-124. (doi:10.1016/j.canlet.2004.10.007)
39. Volzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, Aumann N, Lau K, Piontek M, Born G et al. 2010 Cohort Profile: The Study of Health in Pomerania. International Journal of Epidemiology [in press]. (doi:10.1093/ije/dyp394)
40. Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson JA, Nilsson S et al. 1999 The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Molecular Endocrinology 13 1672-1685. (doi:10.1210/me.13.10.1672)
41. Xie LQ, Yu JP & Luo HS 2004 Expression of estrogen receptor beta in human colorectal cancer. World Journal of Gastroenterology 10 214-217.
42. Xita N & Tsatsoulis A 2010 Genetic variants of sex hormone-binding globulin and their biological consequences. Molecular and Cellular Endocrinology 316 60-65. (doi:10.1016/j.mce.2009.08.025)
43. Xu X & Thomas ML 1994 Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro. Molecular and Cellular Endocrinology 105 197-201. (doi:10.1016/0303-7207(94)90170-8)